People
Sebela Pharmaceuticals names head of Research and Development for new Sebela Women's Health division
16 November 2022 -

Sebela Pharmaceuticals, a United States-based pharmaceutical company, announced on Tuesday that it has named Kelly Culwell, MD, as Head of Research and Development for the new established division named Sebela Women's Health.

Culwell has over 20 years of experience in women's health across public, private and non-profit organisations. She has served as senior vice president and chief medical officer at Afaxys, Inc, chief medical officer at Evofem Biosciences and served in various leadership roles at WCG (formerly WomenCare Global), Planned Parenthood of the Pacific Southwest, and at the International Planned Parenthood Federation in London, UK. She has also served as an assistant professor at University of California at Davis and held a position at the World Health Organization in Geneva, Switzerland as a medical officer/research assistant professor. She has served as senior vice president and chief medical officer at Afaxys, Inc. and chief medical officer at Evofem Biosciences.

Dr Culwell said, 'I am delighted to join Sebela Women's Health and I look forward to working with the team to enrich the health and well-being of women, and the lives of those who care about them. In addition to my training as a women's health physician, I have had the unique opportunity to work in both global and US public health settings as well as in private industry, and I hope to bring these learnings to the development of next-generation products with innovative features that acknowledge and prioritise the needs of women today.'

Login
Username:

Password: